These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2943127)

  • 1. [Effect of oxalysine on pulmonary metastases of Lewis lung carcinoma in mice].
    Yue XF; Wu FG; Xu B
    Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):198-200. PubMed ID: 2943127
    [No Abstract]   [Full Text] [Related]  

  • 2. [The anticancer and pharmacologic study of oxalysine (author's transl)].
    Yue XF; Wu FG; Xu B
    Yao Xue Xue Bao; 1980 Jul; 15(7):391-5. PubMed ID: 6775491
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of oxalysine on plasma fibrinogen content in tumor-bearing mice (author's transl)].
    Yue XF; Wu FG; Xu B
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):124-8. PubMed ID: 6214145
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of tranexamic acid and urokinase on hematogenous metastases of Lewis lung carcinoma in mice.
    Tanaka N; Ogawa H; Tanaka K; Kinjo M; Kohga S
    Invasion Metastasis; 1981; 1(3):149-57. PubMed ID: 7188385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antineoplastic activity of antibiotic 1719 from the group of diazo compounds].
    Shorin VA; Averbukh LA; Bazhanov VS; Lepeshkina GN; Grinshteĭn AM
    Antibiotiki; 1972 Aug; 17(8):675-80. PubMed ID: 4678532
    [No Abstract]   [Full Text] [Related]  

  • 6. Antineoplastic activity of planar rhodium(I) complexes in mice bearing Lewis lung carcinoma and P388 leukemia.
    Sava G; Zorzet S; Mestroni G; Zassinovich G
    Anticancer Res; 1985; 5(3):249-52. PubMed ID: 4015038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hemostasis modifiers of the activity of VP 16 213 on Lewis lung carcinoma.
    Cattan A; Pourny C; Carpentier Y; Cattan E; Barouh M
    Biomedicine; 1977 Jul; 27(5):203-8. PubMed ID: 922120
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of oxalysine (I-677) on the incorporation of lysine and its subcellular distribution].
    Yue XF; Wu SY; Wu FG; Gui JZ; Xu B
    Zhongguo Yao Li Xue Bao; 1983 Mar; 4(1):54-7. PubMed ID: 6223501
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapeutic responses of a primary tumor and its pulmonary metastases in murine tumor systems in relation to its proliferative properties].
    Ohno K
    Osaka Daigaku Shigaku Zasshi; 1984 Jun; 29(1):64-85. PubMed ID: 6590823
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunopotentiating effects of oxalysine].
    Li XY; Tong LM; Jin YF; Cao CY; Liang HZ; Wang JF; Zhu PP; Wang JY
    Zhongguo Yao Li Xue Bao; 1987 Mar; 8(2):173-7. PubMed ID: 2959008
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide chemotherapy of intrapulmonarily implanted Lewis lung carcinoma.
    Ho W; Furst A
    Proc West Pharmacol Soc; 1978; 21():397-400. PubMed ID: 693524
    [No Abstract]   [Full Text] [Related]  

  • 12. Antineoplastic effects of egg-white lysozyme in mice bearing solid metastasizing tumors.
    Sava G; Perissin L; Zorzet S; Callerio C
    Anticancer Res; 1986; 6(2):183-6. PubMed ID: 3707053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of interferon on the toxic effect and antitumor activity of vinblastine in the combined therapy of metastatic Lewis carcinoma].
    Vorontsova AL; Kudriavets IuI; Fadeev VA
    Eksp Onkol; 1984; 6(6):54-7. PubMed ID: 6084588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of microbial fractions and vehicle on survival of mice bearing Lewis lung carcinoma.
    Richman SP; Chism VT; Murphy SG
    Cancer Treat Rep; 1980; 64(12):1329-33. PubMed ID: 7471123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic growth of 3-Lewis lung carcinoma in mice treated with alkyl-lysophospholipids and lysophospholipid-induced peritoneal macrophages.
    Berdel WE; Munder PG
    Anticancer Res; 1981; 1(6):397-402. PubMed ID: 7344614
    [No Abstract]   [Full Text] [Related]  

  • 16. [No promoting effects of sodium tanshinone II-A sulfonate on growth and metastasis of Lewis carcinoma].
    Liu MZ; Huang YS; Xiao WQ
    Zhongguo Yao Li Xue Bao; 1991 Nov; 12(6):534-7. PubMed ID: 1824008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory action of flurbiprofen and mopidamole on tumor lung metastasis formation in mice.
    Mamytbeková A; Rezábek K; Grimová J; Svobodová J
    Cancer Treat Rep; 1987 Nov; 71(11):1089-90. PubMed ID: 3677114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. I. Dose-dependence and kinetics of cyclophosphamide effect.
    Strzadała L; Rak J; Kuśnierczyk H
    Arch Immunol Ther Exp (Warsz); 1985; 33(6):825-9. PubMed ID: 3833119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurohormonal changes during the growth of metastatic Lewis carcinoma in C57Bl mice].
    Shmal'ko IuP; Pridatko OE; Smelkova MI
    Vopr Med Khim; 1985; 31(3):57-60. PubMed ID: 2862742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic characterization of the subcutaneously implanted Lewis lung tumor.
    Mayo JG
    Cancer Chemother Rep 2; 1972 Nov; 3(1):325-30. PubMed ID: 4660735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.